The pAB5 plasmid is a large conjugative plasmid (LCP) identified in the multidrug-resistant (MDR) strain Acinetobacter baumannii UPAB1. It plays a critical role in regulating bacterial virulence and biofilm formation .
The plasmid-encoded H-NS protein silences the chromosomal pgaA-D cluster, which is responsible for PNAG production . This results in:
PNAG Reduction: Drastically lowers extracellular matrix components critical for biofilm stability .
Curli Suppression: Represses a three-gene cluster homologous to CsgG, involved in amyloid fiber assembly .
Transcriptomic Analysis: pAB5 downregulates cell-surface components like chaperone/usher pathway (CUP) pili .
Phenotypic Validation: Congo red assays confirm reduced phenotypic expression of PNAG in pAB5-carrying strains .
While no direct data on "PAB5 Antibody" exists, discusses polyreactive antibodies (e.g., IgM, IgA) that bind diverse antigens with low affinity. Their role in innate immunity and potential therapeutic applications remain under investigation .
This antibody targets PAB5, a protein that binds to the poly(A) tail of messenger RNA (mRNA). PAB5 plays a crucial role in various aspects of mRNA metabolism, including biogenesis, stability, and translation.
PAB5 in Arabidopsis thaliana (UniProt: Q05196) is a plant-specific protein that plays important roles in cellular functions. Based on available data, researchers primarily use antibodies against this protein for plant science investigations. The antibody specifically targets recombinant Arabidopsis thaliana PAB5 protein, making it a valuable tool for investigating plant molecular biology .
The PAB5 antibody (CSB-PA787831XA01DOA) has been specifically validated for ELISA and Western Blot applications. These methodologies enable researchers to detect and quantify PAB5 protein expression across different experimental conditions. The antibody has undergone antigen affinity purification to ensure specificity for its target .
For optimal performance, store the PAB5 antibody at -20°C or -80°C upon receipt. Avoid repeated freeze-thaw cycles as these can degrade antibody quality and performance. The antibody is supplied in liquid form in a buffer containing 0.03% Proclin 300, 50% Glycerol, and 0.01M PBS at pH 7.4. For long-term storage stability, maintain at -20°C where it remains stable for at least one year when properly stored .
Polyclonal antibodies like the PAB5 antibody are produced from multiple B-cell lineages and recognize multiple epitopes on the target antigen. This characteristic provides high sensitivity across various applications but potentially lower specificity compared to monoclonal antibodies. In contrast, monoclonal antibodies derive from a single B-cell lineage, recognizing a single epitope and offering higher specificity. The polyclonal nature of the PAB5 antibody makes it particularly suitable for detection applications where sensitivity is paramount .
The PAB5 antibody demonstrates specific reactivity against Arabidopsis thaliana samples. It was raised against recombinant Arabidopsis thaliana PAB5 protein, making it particularly suitable for plant research focusing on this model organism. Researchers should validate cross-reactivity if planning to use this antibody with other plant species .
When conducting Western blot experiments with the PAB5 antibody, incorporate the following controls for reliable results:
Positive control: Sample with confirmed PAB5 expression
Negative control: Sample lacking PAB5 expression
Loading control: Detection of a housekeeping protein (e.g., actin or tubulin)
Molecular weight marker: To verify the observed band matches the expected size of PAB5
Secondary antibody-only control: To identify non-specific binding
These controls help validate specificity and ensure experimental rigor. For Western blot applications, appropriate dilution optimization should be performed to achieve optimal signal-to-noise ratio .
For optimal PAB5 detection in Arabidopsis thaliana tissues:
Harvest fresh tissue and flash-freeze in liquid nitrogen
Grind tissue to a fine powder while maintaining freezing conditions
Extract proteins using a buffer containing protease inhibitors to prevent degradation
Include reducing agents (e.g., DTT or β-mercaptoethanol) to maintain protein structure
Clarify the extract through centrifugation (e.g., 13,000 × g for 10 minutes at 4°C)
Quantify protein concentration using Bradford or BCA assay
Denature samples in SDS sample buffer for Western blotting or prepare accordingly for ELISA
This methodical approach ensures preservation of protein integrity and maximizes detection sensitivity .
To determine the optimal PAB5 antibody concentration:
Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000)
Run identical samples with each dilution
Compare signal-to-noise ratios across the dilution range
Select the dilution providing the strongest specific signal with minimal background
Validate the chosen concentration with appropriate positive and negative controls
This systematic titration approach ensures efficient antibody usage while maximizing detection specificity .
Plant tissues present unique challenges for protein extraction and antibody-based detection:
Cell wall barriers require efficient mechanical disruption
Phenolic compounds and oxidative enzymes can interfere with antibody binding
Secondary metabolites may cause non-specific background
High proteolytic activity necessitates robust protease inhibitor cocktails
Polysaccharides can affect protein separation and detection
To address these challenges, consider specialized extraction methods such as TCA/acetone precipitation or phenol extraction protocols specifically optimized for plant tissues .
For comprehensive antibody validation:
Perform epitope blocking experiments using the immunizing peptide
Include known positive and negative control samples
Compare results across multiple detection methods (e.g., ELISA and Western blot)
Use genetic knockdown/knockout samples when available
Consider peptide competition assays to confirm epitope specificity
These validation steps ensure experimental rigor and confidence in the specificity of detected signals .
High background in Western blots can result from:
Insufficient blocking: Extend blocking time or try alternative blocking reagents
Excessive antibody concentration: Perform additional titration experiments
Inadequate washing: Increase wash duration and frequency
Sample overloading: Reduce protein loading amount
Cross-reactivity: Validate antibody specificity with additional controls
Buffer contamination: Prepare fresh buffers for each experiment
Methodological adjustments to address these issues include optimizing blocking conditions (5% non-fat milk or BSA), increasing wash steps, and carefully titrating antibody concentrations .
To improve ELISA signal detection:
Optimize coating buffer composition and concentration
Extend primary antibody incubation time (consider overnight at 4°C)
Adjust blocking buffer composition (test BSA, milk, or commercial alternatives)
Increase sample concentration if signal is weak
Consider signal amplification systems (e.g., biotin-streptavidin)
Use high-sensitivity substrates for detection
Maintain consistent temperature throughout the assay
These methodological refinements can significantly enhance assay sensitivity and reproducibility when working with plant samples .
Multiple bands in Western blots may result from:
Post-translational modifications of the target protein
Proteolytic degradation during sample preparation
Splice variants or isoforms of the target protein
Cross-reactivity with related proteins
Sample overloading causing streaking
To address these issues:
Include protease inhibitor cocktails during extraction
Use freshly prepared samples
Optimize denaturing conditions
Reduce protein loading amount
For consistent, reproducible results:
Maintain detailed records of antibody lot numbers and storage conditions
Standardize sample preparation protocols and protein quantification methods
Use the same dilution buffers and blocking reagents across experiments
Maintain consistent incubation times and temperatures
Include internal controls in each experiment
Perform technical replicates for critical experiments
Prepare fresh working solutions for each experimental session
This systematic approach minimizes technical variability and enhances data reliability .
Weak or absent signals may result from:
Low target protein abundance: Increase sample concentration
Antibody degradation: Verify storage conditions and prepare fresh working dilutions
Inefficient protein transfer (for Western blots): Optimize transfer conditions
Epitope masking: Adjust sample preparation to enhance epitope accessibility
Incompatible detection system: Test alternative detection methods
Solutions include concentrating samples, reducing sample complexity through fractionation, extending primary antibody incubation time, and verifying antibody activity with known positive controls .
For investigating PAB5 protein interactions:
Immunoprecipitation (IP): Use the PAB5 antibody to pull down protein complexes, followed by mass spectrometry analysis
Co-immunoprecipitation (Co-IP): Identify interacting partners by precipitating PAB5 and detecting associated proteins
Proximity ligation assay (PLA): Visualize protein interactions in situ
Pull-down assays: Use recombinant PAB5 as bait to identify binding partners
Cross-linking studies: Stabilize transient interactions before immunoprecipitation
These approaches provide complementary data on protein-protein interactions in plant systems .
Post-translational modifications (PTMs) can significantly impact antibody recognition:
Phosphorylation, glycosylation, or other PTMs may mask or alter epitopes
Changes in protein conformation due to PTMs can affect antibody binding
Some antibodies may preferentially recognize specific modified forms
To address these considerations:
Compare results with phosphatase or glycosidase-treated samples
Consider using modification-specific antibodies for comprehensive analysis
Validate results using alternative detection methods like mass spectrometry
Perform epitope mapping to understand potential interference from PTMs
For quantitative comparative analysis:
Quantitative Western blotting:
Use fluorescently-labeled secondary antibodies for wider dynamic range
Include standard curves with recombinant protein
Normalize to loading controls or total protein stain
Quantitative ELISA:
Develop standard curves with purified recombinant protein
Use technical replicates to determine coefficient of variation
Include reference samples across multiple plates
Data analysis:
For subcellular localization of PAB5:
Cell fractionation followed by Western blot analysis:
Separate cellular compartments using differential centrifugation
Verify fraction purity with compartment-specific markers
Detect PAB5 in different fractions using Western blotting
Indirect immunofluorescence (if validated for this application):
Optimize fixation and permeabilization for plant cells
Include appropriate controls for antibody specificity
Co-stain with organelle markers for precise localization
These approaches provide complementary information about PAB5 distribution within plant cells .
For investigating PAB5 in stress responses:
Time-course experiments:
Subject plants to various stressors (drought, salt, pathogens)
Collect samples at multiple time points
Analyze PAB5 expression changes using Western blot or ELISA
Comparative analysis:
Compare PAB5 levels between stress-resistant and susceptible varieties
Correlate PAB5 expression with physiological parameters
Integrate with transcriptomic or metabolomic data
Genetic approaches:
| Parameter | Specification |
|---|---|
| Product Code | CSB-PA787831XA01DOA |
| Target Protein | PAB5 (UniProt: Q05196) |
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Species Reactivity | Arabidopsis thaliana |
| Validated Applications | ELISA, Western Blot |
| Immunogen | Recombinant Arabidopsis thaliana PAB5 protein |
| Purification Method | Antigen Affinity Purified |
| Storage Buffer | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4 |
| Form | Liquid |
| Recommended Storage | -20°C or -80°C |
| Stability | Stable for at least 1 year when properly stored |
| Lead Time | Made-to-order (14-16 weeks) |
This comprehensive specification table provides researchers with essential information for experimental planning and comparison with other antibodies .
The PAB5 antibody has been validated for both ELISA and Western blot applications, each offering distinct advantages:
ELISA: Provides quantitative analysis with high sensitivity, suitable for screening multiple samples in parallel. Particularly useful for comparative studies of PAB5 expression levels across different experimental conditions.
Western Blot: Offers information about protein size and potential post-translational modifications or degradation products. Enables semi-quantitative analysis of PAB5 expression when properly controlled.
Researchers should select the appropriate application based on their specific research questions and available sample types .
For reproducible quantification:
Sample preparation standardization:
Consistent tissue collection and processing
Identical protein extraction protocols
Accurate protein quantification
Technical considerations:
Consistent antibody dilutions across experiments
Standard curve inclusion for absolute quantification
Multiple technical replicates to assess variability
Internal controls across experimental batches
Data analysis:
The PAB5 antibody undergoes several quality control measures:
Antigen affinity purification to ensure specificity
Application-specific validation for ELISA and Western blot
Species reactivity testing for confirmed performance with Arabidopsis thaliana
Batch-to-batch consistency verification
Storage stability testing for long-term performance
These quality control measures help ensure reliable experimental outcomes when using this antibody for plant research applications .
When interpreting PAB5 detection data:
Consider biological context:
Developmental stage of plant material
Environmental conditions during growth
Tissue-specific expression patterns
Comparative analysis:
Use appropriate statistical methods for comparisons
Consider biological versus technical variability
Interpret changes in relation to experimental treatments
Validation approaches:
Correlate protein levels with transcript abundance
Compare antibody-based detection with other methods
Integrate findings with existing knowledge about PAB5 function